ADVL1217, A PHASE 1 STUDY OF MK-1775 (IND#116459) CONCURRENT WITH LOCAL RADIATION THERAPY FOR THE TREATMENT OF NEWLY DIAGNOSED CHILDREN WITH DIFFUSE INTRINSIC PONTINE GLIOMAS

Registry ID

ADVL1217

Source registry

HEALTH_CANADA

Status

Closed

Phase

PHASE1

Study type

INTERVENTIONAL

Sponsor

CHILDRENS ONCOLOGY GROUP

Start date

2014-03-19

Completion date

2017-02-06

Last update

2013-08-29

Conditions

• DIFFUSE INTRINSIC PONTINE GLIOMAS

Related clinical trials

• A PILOT STUDY OF SAFETY, TOLERABILITY, AND IMMUNOLOGICAL EFFECTS OF SURVAXM IN PEDIATRIC PATIENTS WITH PROGRESSIVE OR RELAPSED MEDULLOBLASTOMA, HIGH GRADE GLIOMA, EPENDYMOMA AND NEWLY DIAGNOSED DIFFUSE INTRINSIC PONTINE GLIOMA

View on source registry